Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer

Leukemia

Volumn 13, Issue 10, 1999, Pages 1608-1616

  Howard, D S ^a   Rizzierri, D A ^b   Grimes, B ^a   Upchurch, D ^a   Phillips, G L ^a   Stewart, A K ^c   Yannelli, J R ^a   Jordan, C T ^a,d  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Acute myelogenous leukemia (AML); Adenovirus; CD80; Gene transfer; Hematopoietic; Leukemia

Indexed keywords

B7 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CYTOKINE; VIRUS VECTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADENOVIRUS; ARTICLE; CELL TYPE; CONTROLLED STUDY; GENE TRANSFER; GENETIC MANIPULATION; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOCYTE CULTURE; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

EID: 0032855019     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401541     Document Type: Article

References (43)

1. - human hematopoietic progenitors assessed in immune-deficient mice. Blood 1998; 91: 1243-1255.
2. Jordan CT, Lemischka IR. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev 1990; 4: 220-232.
3. Szilvassy SJ, Fraser CC, Eaves CJ, Lansdorp PM, Eaves AC, Humphries RK. Retrovirus-mediated gene transfer to purified hemopoietic stem cells with long-term lympho-myelopoietic repopulating ability. Proc Natl Acad Sci USA 1989; 86: 8798-8802.
4. Karlsson S. Gene therapy of haematopoietic cells. J Intern Med Suppl 1997; 740: 95-99.
5. Chatterjee S, Li W, Wong CA, Fisher-Adams G, Lu D, Guha M, Macer JA, Forman SJ, Wong KK Jr. Transduction of primitive human marrow and cord blood-derived hematopoietic progenitor cells with adeno-associated virus vectors. Blood 1999; 93: 1882-1894.
6. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 1999; 283: 682-686.
7. Case SS, Price MA, Jordan CT, Yu XJ, Wang L, Bauer G, Haas DL, Xu D, Stripecke R, Naldini L, Kohn DB, Crooks GM. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-4-based lentiviral vectors. Proc Natl Acad Sci USA 1999; 96: 2988-2993.
8. Uchida N, Sutton RE, Friera AM, He D, Reitsma MJ, Chang WC, Veres G, Scollay R, Weissman IL. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc Natl Acad Sci USA 1998; 95: 11939-11944.
9. + cells. Hum Gene Ther 1998; 9: 2727-2734.
10. Neering SJ, Hardy SF, Minamoto D, Spratt SK, Jordan CT. Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors. Blood 1996; 88: 1147-1155.
11. Frey BM, Hackett NR, Bergelson JM, Finberg R, Crystal RG, Moore MA, Rafili S. High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors. Blood 1998; 91: 2781-2792.
12. + cells. Gene Therapy 1998; 5: 465-472.
13. Fasbender A, Zabner J, Chillon M, Moninger TO, Puga AP, Davidson BL, Welsh MJ. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J Biol Chem 1997; 272: 6479-6489.
14. Wickham TJ, Tzeng E, Shears LL, Roelvink PW, Li Y, Lee GM, Brough DE, Lizonova A, Kovesdi I. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J Virol 1997; 71: 8221-8229.
15. Douglas JT, Miller CR, Kim M, Dmitriev I, Mikheeva G, Krasnykh V, Curiel DT. A system for the propagation of adenoviral vectors with genetically modified receptor specificities. Nat Biotechnol 1999; 17: 470-475.
16. Byk T, Haddada H, Vainchenker W, Louache F. Lipofectamine and related cationic lipids strongly improve adenoviral infection efficiency of primitive human hematopoietic cells. Hum Gene Ther 1998; 9: 2493-2502.
17. Tang MX, Redemann CT, Szoka FC Jr. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem 1996; 7: 703-714.
18. Dranoff G, Soiffer R, Lynch T, Mihm M, Jung K, Kolesar K, Liebster L, Lam P, Duda R, Mentzer S, Singer S, Tanabe K, Johnson R, Sober A, Bhan A, Clift S, Cohen L, Parry G, Rokovich J, Richards L, Drayer J, Berns A, Mulligan RC. A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor. Hum Gene Ther 1997; 8: 111-123.
19. Stewart AK, Lassam NJ, Graham FL, Gauldie J, Addison CL, Bailey DJ, Dessureault S, Dube ID, Gallenger S, Krajden M, Rotstein LE, Quirt IC, Moen R. A phase I study of adenovirus mediated gene transfer of interleukin 2 cDNA into metastatic breast cancer or melanoma. Hum Gene Ther 1997; 8: 1403-1414.
20. Bain C, Merrouche Y, Puisieux I, Duc A, Colombo MP, Favrot M. B7.1 gene transduction of human renal-cell-carcinoma cell lines restores the proliferative response and cytotoxic function of allogeneic T cells. Int J Cancer 1996; 67: 769-776.
21. Schultze J, Nadler LM, Gribben JG. B7-rnediated costimulation and the immune response. Blood Rev 1996; 10: 111-127.
22. Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML. Construction of adenovirus vectors through Cre-lox recombination. J Virol 1997; 71: 1842-1849.
23. Dessureauit S, Graham F, Gallinger S. B7-1 gene transfer into human cancer cells by infection with an adenovirus-B7 (Ad-B7) expression vector. Ann Surg Oncol 1996; 3: 317-324.
24. Prevec L, Graham FL. Methods in Molecular Biology: Gene Transfer and Expression Protocols. Humana Press: Clifton, NJ, 1991.
25. Jordan CT, Yamasaki G, Minamoto D. High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations. Exp Hematol 1996; 24: 1347-1355.
26. Prince HM, Dessureault S, Gallinger S, Krajden M, Sutherland DR, Addison C, Zhang Y, Graham FL, Stewart AK. Efficient adenovirus-mediated gene expression in malignant human plasma cells: relative lymphoid cell resistance. Exp Hematol 1998; 26: 27-36.
27. Cantwell MJ, Sharma S, Friedmann T, Kipps TJ. Adenovirus vector infection of chronic lymphocytic leukemia B cells. Blood 1996; 88: 4676-4683.
28. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med 1997; 3: 730-737.
29. Blair A, Hogge DE, Sutherland HJ. Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR-. Blood 1998; 92: 4325-4335.
30. Poncet P, Panczak A, Goupy C, Gustafsson K, Blanpied C, Chavanel G, Hirsch R, Hirsch F. Antifection: an antibody-mediated method to introduce genes into lymphoid cells in vitro and in vivo. Gene Therapy 1996; 3: 731-738.
31. + hematopoietic cells. Biotechniques 1995; 19: 816-823.
32. + cells. Blood Cells Mol Dis 1997; 23: 69-87.
33. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993; 73: 309-319.
34. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.
35. Krasnykh VN, Mikheeva GV, Douglas JT, Curiel DT. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol 1996; 70: 6839-6846.
36. Jordan CT, Zant GV. Recent progress in identifying genes regulating hematopoietic stem cell function and fate. Curr Opin Cell Biol 1998; 10: 716-720.
37. Putzer BM, Hitt M, Muller WJ, Emtage P, Gauldie J, Graham FL. Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression. Proc Natl Acad Sci USA 1997; 94: 10889-10894.
38. Wiznerowicz M, Fong AZ, Mackiewicz A, Hawley RG. Double-copy bicistronic retroviral vector platform for gene therapy and tissue engineering: application to melanoma vaccine development. Gene Therapy 1997; 4: 1061-1068.
39. Medin JA, Migita M, Pawliuk R, lacobson S, Amiri M, Kluepfel-Stahl S, Brady RO, Humphries RK, Karlsson S. A bicistronic therapeutic retroviral vector enables sorting of transduced CD34* cells and corrects the enzyme deficiency in cells from Gaucher patients. Blood 1996; 87: 1754-1762.
40. Tuting T, Storkus WJ, Lotze MT. Gene-based strategies for the immunotherapy of cancer. J Mol Med 1997; 75: 478-491.
41. Dunussi-Joannopoulos K, Weinstein HJ, Arceci RJ, Croop JM. Gene therapy with B7.1 and GM-CSF vaccines in a murine AML model. J Pediatr Hematol Oncol 1997; 19: 536-540.
42. Hirano N, Takahashi T, Takahashi T, Azuma M, Yazaki Y, Yagita H, Hirai H. Protective and therapeutic immunity against leukemia induced by irradiated B7-1 (CD80)-transduced leukemic cells. Leukemia 1997; 11 (Suppl. 3): 577-581.
43. Mutis T, Schrama E, Melief CJ, Goulmy E. CD80-transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens. Blood 1998; 92: 1677-1684.